Headlines

Thermo Fisher Scientific Inc. (TMO) Q4 2025 (USD): Adj. EPS 6.57 (exp. 6.45), Revenue 12.2bln (exp. 11.95bln)

Newsquawk Staff ·

  • Will provide guidance 2026 guidance at its conference call at 13:30 GMT.

What it means

Thermo Fisher Scientific's Q4 results exceeded expectations for both adjusted EPS and revenue, suggesting stronger performance in the life sciences sector. The beat in numbers may reflect effective cost management and robust demand, which could set a positive tone heading into their 2026 guidance announcement. Today's results may impact sentiment across related sectors, particularly pharmaceuticals and biotechnology, and could influence market action in both equities and foreign exchange related to these industries.

Related headlines